Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus
Authors:
- Bimmer E. ClaessenBCBimmer E. Claessen
- Pier WoudstraPWPier Woudstra
- J. Hans DeVriesJDJ. Hans DeVries
- Joanna J. WykrzykowskaJWJoanna J. Wykrzykowska
- Marije M. VisMVMarije M. Vis
- Jan BaanJBJan Baan
- Karel T. KochKKKarel T. Koch
- Jan G.P. TijssenJTJan G.P. Tijssen
- Robbert J. de WinterRWRobbert J. de Winter
- Jan J. PiekJPJan J. Piek
- José P.S. HenriquesJHJosé P.S. Henriques
- 1 May 2014
- journal article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 10 (1) , 90-96
Abstract
We investigated the impact of preadmission diabetic status on long-term outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), to improve risk stratification. Between 1997 and 2007, 4,402 STEMI patients were admitted to our hospital and stratified as having insulin-treated diabetes mellitus (ITDM) (n=176), non-ITDM (NITDM) (n=354) and non-DM (n=3,872). Five-year mortality was significantly higher in patients with DM compared to non-DM (29% vs. 18%, p<0.01). After stratification for preadmission glucose-lowering therapy, five-year mortality was significantly higher in ITDM patients compared to NITDM (36% vs. 25%, p=0.01) and in NITDM patients compared to non-DM patients (25% vs. 18%, p<0.01). After adjustment for age and gender the mortality risk between patients with NITDM versus non-DM was comparable (HR: 1.1, 95% CI: 0.9-1.4, p=0.38), in contrast to patients with ITDM (HR: 1.9, 95% CI: 1.5-2.5, p<0.01) and ITDM versus NITDM (HR: 1.7, 95% CI: 1.2-2.4, p<0.01). After adjustment for all baseline characteristics, the results were comparable to the age and gender adjusted model. ITDM was a strong predictor for long-term mortality when compared to non-DM and NITDM. The mortality between patients without DM and NITDM was comparable after adjustment for age and gender.Keywords
This publication has 28 references indexed in Scilit:
- Long-Term Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusions in Patients With Versus Without Diabetes MellitusThe American Journal of Cardiology, 2011
- Impact of Diabetes Mellitus on the Safety and Effectiveness of Bivalirudin in Patients With Acute Myocardial Infarction Undergoing Primary AngioplastyJACC: Cardiovascular Interventions, 2011
- Comparison of Outcomes in Patients With Insulin-Dependent Versus Non-Insulin Dependent Diabetes Mellitus Receiving Drug-Eluting Stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)†The American Journal of Cardiology, 2010
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)JACC, 2009
- Paclitaxel-Eluting Coronary Stents in Patients With Diabetes MellitusJACC, 2008
- Primary Percutaneous Coronary Intervention Compared With Fibrinolysis for Myocardial Infarction in Diabetes MellitusArchives of internal medicine (1960), 2007
- Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitusHeart, 2006
- Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarctionThe American Journal of Cardiology, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusThe American Journal of Cardiology, 1987